Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and phosphate‐buffered saline
Authors:
Abstract
CC‐4047 is a racemic second‐generation immunomodulatory drug currently in clinical development for various oncologic indications. It has potent effects on key cytokines including tumor necrosis factor‐α, interleukin (IL‐10), and interferon (IFN‐γ). The S‐isomer of CC‐4047 has been reported to be the more potent enantiomer of the racemate. In this article we report on the rapid racemization of the S‐isomer of CC‐4047 in human plasma and phosphate‐buffered saline. These results support the further development of the racemate instead of the S‐isomer. Chirality 15:348–351, 2003.Keywords
This publication has 15 references indexed in Scilit:
- Protective Antitumor Immunity Induced by a Costimulatory Thalidomide Analog in Conjunction with Whole Tumor Cell Vaccination Is Mediated by Increased Th1-Type ImmunityThe Journal of Immunology, 2002
- Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteersXenobiotica, 2002
- Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteersEuropean Journal of Clinical Pharmacology, 2001
- Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaBlood, 2001
- Intravenous Formulations of the Enantiomers of Thalidomide: Pharmacokinetic and Initial Pharmacodynamic Characterization in ManJournal of Pharmacy and Pharmacology, 2000
- Therapeutic potential of TNF-α inhibitors old and newDrug Discovery Today, 1997
- Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomideChirality, 1995
- Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United StatesChirality, 1994
- Isomeric inversion of ibuprofen (r)‐enantiomer in humansJournal of Pharmaceutical Sciences, 1976
- Toxicity and Teratogenicity of Optical Isomers of ThalidomideNature, 1967